| About the author: |
Abdullaev V. A., Bakhshaliyev A. B., Yusifov R. N. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The aim of the study was to examine the effectiveness of rational drug therapy with β-blockers a combination of coronary heart disease and chronic obstructive pulmonary disease.
Methods. Conducted a study of the effect of prolonged use of selective β- blockers nebivolol at the same time of day, with liquid, squeezed enough water during or after meals - 5 mg 1 time per day. We studied 58 patients (COPD+CHD - 32 patients, CHD - 26 patients), a leading pathology among whom were ischemic heart disease, demonstrate by angina and/or arrhythmia.
In all patients the diagnosis of CHD was confirmed by instrumental studies, stress ECHO, ECG monitoring; biochemical studies of total cholesterol, triglycerides, LDL and HDL. The presence of COPD was diagnosed on the basis of survey data, medical history, physical and instrumental examination - x-ray examination of chest organs, respiratory function, analysis of blood gases and blood oxygen saturation, General and biochemical blood tests, sputum examination. All the patients had history of Smoking was estimated on the basis of who proposed indicators: the index of the smoker and the number of packs/years. Results. Chronotropic efficacy of nebivolol was never in doubt. Selected doses were sufficient to achieve the target heart rate and reduced resting heart rate at 11.25±9,97 beats/min and under a load. Maximum heart rate during symptom-limited samples during therapy was less 15,58±9,15 BPM is Not statistically significant drug effect on bronchial patency: FEV1 was 2,09±0,98 ml before treatment and 2,59±1,14 ml in the process. Conclusions. Monotherapy by nebivolol helps to normalize blood pressure in most patients with hypertensive disease of the 1st and 2nd degree. Nebivolol does not cause orthostatic hypotension, disturbances of lipid and carbohydrate metabolism, does not affect the performance of the functions of external respiration, including in patients with COPD.
|
| Tags |
β-blockers, the combination of ischemic heart disease and chronic obstructive pulmonary disease |
| Bibliography |
- Zadionchenko V. S. Korrekcija jendotelial'noj disfunkcii u bol'nyh hronicheskim legochnym serdcem kardioselektivnymi β-adrenoblokatorami / V. S. Zadionchenko, A. M. Shhikota, I. V. Pogonchenkova [i dr.] // Russkij med. zhurnal. - 2007, № 4, S. 285–289.
- Kadaeva D. A. Ocenka jeffektivnosti i bezopasnosti primenenija selektivnyh β-adrenoblokatorov nebivolola i bisoprolola pri narushenijah ritma serdca u bol'nyh HOBL pozhilogo i starcheskogo vozrasta. / D. A. Kadaeva, K. A. Masuev, M. I. Ibragimova // Pul'monologija. - 2009, №5, S. 68–72.
- Ovcharenko S.I. Selektivnye β-adrenoblokatory (nebivolol i metoprolola sukcinat) v terapii bol'nyh arterial'noj gipertoniej i/ili ishemicheskoj bolezn'ju serdca v sochetanii s bronhoobstruktivnym sindromom: ocenka jeffektivnosti i bezopasnosti. / S.I. Ovcharenko, I.V. Litvinova, V.I. Makolkin // Pul'monologija. - 2008, № 3, S. 28–34.
- Simonova Zh. G. Ocenka bezopasnosti primenenija kardioselektivnogo β-adrenoblokatora nebivolola v kompleksnoj terapii bol'nyh ishemicheskoj bolezn'ju serdca s soputstvujushhim hronicheskim obstruktivnym bronhitom. / Zh. G. Simonova, E. I. Tarlovskaja, A. K. Tarlovskij // Bjulleten' SO RAMN № 3 (109), - 2003.
- Sudakov O. V. Ispol'zovanie β-blokatorov v gipotenzivnoj terapii bol'nyh hronicheskimi obstruktivnymi boleznjami legkih. / O.V. Sudakov, Je.V. Minakov // Zhurnal teoreticheskoj i prakticheskoj mediciny. - 2004, T. 2. № 1, S. 30–33.
- Shljahov U. I.Hronicheskaja obstruktivnaja bolezn' legkih./ U.I. Shljahov // Pul'monologija, izbrannye voprosy. - 2001, № 2, S. 1–9.
- Shilov A. M. Osobennosti lechenija IBS v sochetanii s HOBL. / A. M. Shilov, O. F. Tarasenko, A. O. Osija // Lechashhij Vrach. - 2009, № 7, S. 44–48.
- Chatterjee S. S.The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. / S. S.Chatterjee // J. Cardiovasc. Pharmacol. - 1986, № 8. Р. 74–77.
- Chen J. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. / J. Chen, M.J. Radford, Y. Wang [et al.] // J Am Coll Cardiol. - 2001, Vol. 37, P. 1950–1956.
- Dranseld M. T. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD / M.T.Dranseld, S.M.Rowe, J.E. Johnson [et al.] // Thorax. - 2008, Vol. 63, P. 301–305.
- Dal Negro R. Pulmonary effects of nebivolol. / R. Dal Negro // Therapeutic advances in cardiovascular disease. - 2009, Aug, Vol. 3 (4), P. 329–334.
- Jabbour A. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. / A Jabbour, P.S. Macdonald, A.M. Keogh [et al.] // J Am Coll Cardiol. 2010, Apr 27, Vol. 55 (17), P. 1780–1787.
|
| Publication of the article |
«World of Medicine and Biology» №4(53) 1 part 2015 year, 008-012 pages, index UDK 616.127-084, 616.12-005.4+616.24-002.2-08 |
